CLAIM CARD
The background evidence for carnosine anti glycation is heterogeneous rather than uniformly confirmatory. Direct clinical sources such as Movahedian 2025, Ozdemir 2025 are interpreted separately from mechanistic studies such as the retained evidence base, because these evidence roles answer different questions about aging biology and clinical translation.
Evidence grade: exploratory
Contradiction status: none
Publication: 9f7abff5-de87-4959-b080-10eac9863ba7
Provenance: Derivation Web chain
Citation Support
source_1Movahedian 2025source_2Kopytek 2025source_3Kabthymer 2024source_4Li 2025source_5Dahlen 2025